Table 2.
Subject# | MBP | MCPP | MBzP | MEHP | MEOHP | MEHHP | MECPP | MEP | MiBP |
---|---|---|---|---|---|---|---|---|---|
Population Geometric Mean** | 21.1 | 2.91 | 13.7 | 2.34 | 14.5 | 21.7 | 34.7 | 193 | 3.8 |
Population 95%ile** | 122 | 15.3 | 101 | 31 | 157 | 266 | 339 | 2700 | 21.3 |
Participant 1 | 9888 | 116 | 1.1 | <LOD | 12.1 | 20.9 | 39.4 | 36.2 | 19.3 |
Participant 2 | 17.5 | 5.8 | 14.8 | 3.4 | 28.3 | 52.8 | 92.7 | 2739 | 7 |
Participant 3 | 12308 | 163 | 19 | 5 | 35.5 | 64.4 | 92.7 | 300 | 30.7 |
Participant 4 | 10124 | 72.6 | 9.3 | 4.8 | 35 | 61.1 | 90.3 | 412 | 21.1 |
Participant 5 | 41590 | 560 | 10.8 | 10.6 | 34.4 | 59.2 | 67.2 | 350 | 59.3 |
Abbreviations: MBP = Mono-n-butyl phthalate; MBzP = Monobenzyl phthalate; MCPP = Mono-3-carboxypropyl phthalate; MECPP = Mono-2-ethyl-5-carboxypentyl phthalate; MEHHP = Mono-2-ethyl-5-hydroxyhexyl phthalate; MEHP = Mono-2-ethylhexyl phthalate; MEOHP = Mono-2-ethyl-5-oxohexyl phthalate; MEP = Monoethyl phthalate; MiBP = Mono-isobutyl phthalate LOD = limit of detection. LOD (in ng/mL): mECPP = 0.25; mEHHP = 0.32; MEOHP = 0.45; mEHP = 0.9; mCPP = 0.16; miBP = 0.26; mBP = 0.4; mBzP = 0.11; mEP = 0.4;
www.cdc.gov/exposurereport (NHANES 2003–2004) - accessed 05/10/10